vitreous-tamponades-market

Vitreous Tamponades Market By Type (Gas Tamponades, Liquid Tamponades) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

24 Feb 2019 Format PDF icon PPT icon XLS icon Request Sample

In the recent years, vitreoretinal surgery has made prominent progress with respect to the drugs, materials and instrumentation. Several ophthalmic conditions such as diabetic retinopathy, proliferative vitreoretinopathy and diabetic retinopathy total or partial vitreous removal. At present, permanent and temporary vitreous substitutes have structural function for ensuring retinal adherence following retinopexy or for control of intraocular hemorrhages and maintenance of intraocular pressure. It is anticipated that, the future polymers used as vitreous substitutes will favorably interact with the intraocular anatomy along with ensuring appropriate intraocular drug distribution. However, one of the most significant challenges is with respect to the control of immune reactions modifying stability of substitutes and functionality of intraocular structures.

"Gas tamponades to continue to dominate the global market"

Since its introduction, intraocular gas tamponades have been a vital part of vitreoretinal surgery. At present, sulfur hexafluoride and perfluoropropane are most commonly used in treatment of complicated vitreoretinal diseases. They are heavier than air, odorless, nontoxic and colorless and retain their tamponades effect owing to better surface tension. Both the gas types were approved by the USFDA in 1993 for being used for pneumatic retinopexy. Sulfur hexafluoride is commonly used retinal surgeries, as the gas expands in the cavity within one to two days of the surgery and remains there for a period of one to two weeks. Additionally, perfluoropropane expands to four times of the original volume in three to five days of injection and remains in the vitreous cavity for six to eight weeks. Due to their better buoyancy, gas tamponades assist in maintaining the desired position of retina against the RPE; however, this effect is restricted to the upper part and therefore does not affect the inferior retina. The adverse effects of gas tamponades is increase of pressure during surgery and until a few days after injection, cataract formation and endothelial changes in the cornea. The use of liquid materials as adjunctive agents in retinal surgery plays a prominent role in treating retinal detachment. The use of liquid materials as adjunct to vitreo-retinal surgery has an important role in ensuring retinal reattachment. Such products are often used in intraoperative settings for reinstating intraocular volume and separating retina adherent membranes.

"Asia Pacific to witness rapid growth in demand for vitreous tamponades"

In 2017, North America is estimated as the largest regional market for vitreous tamponades, followed by Europe. Widespread usage of vitreous tamponades in ocular surgeries, greater awareness and favorable reimbursements are the key factors that support the dominance of these regions. On the other hand, these regions also witness fastest adoption of new technologies and methods in the mainstream operations due to favorable regulations, better purchasing powers and domicile of major market players. On the other hand, Asia Pacific market shall be advancing at rapid growth rate registering higher than the global benchmark. Rapid growth of the healthcare infrastructure in the region, and high prevalence of diabetes and therefore diabetic retinopathy along with improving awareness in the healthcare providers are supporting the pace of Asia Pacific market. Furthermore, the development of Asia Pacific market as a hub for medical tourism will open additional growth opportunities in the region.

The major players profiled in this report include Carl Zeiss Meditec AG, Dutch Ophthalmic Research Center (International) B.V., AL.CHI.MI.A Srl, Valeant Pharmaceuticals International, Inc., Fluoron GmbH, Novartis AG, Alcon, Inc., CROMA-PHARMA GmbH and Arcadophta.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Vitreous Tamponades market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Vitreous Tamponades market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

ATTRIBUTE DETAILS
Research Period  2022-2032
Base Year 2023
Forecast Period  2024-2032
Historical Year  2022
Unit  USD Million
Segmentation
Type
  • Gas Tamponades
    •     Sulfur Hexafluoride (SF6)
    •     Perfluoroethane (C2F6)
    •     Perfluoropropane (C3F8)
  • Liquid Tamponades
    •     Silicone Oil
    •     Perfluorocarbon Liquids (PFCL)

 Region Segment (2022-2032; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Vitreous Tamponades market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2032.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Vitreous Tamponades market?
  • Which is the largest regional market for Vitreous Tamponades market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Vitreous Tamponades market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Vitreous Tamponades market worldwide?
Choose Licence Type
$4325
$6325
$12650
Why Acute
View Other Reports